FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter Lundbeck Seattle BioPharmaceuticals, Inc. BLA 761119
Letter
BLA 761119
Lundbeck Seattle BioPharmaceuticals, Inc.
FDA.report
›
FDA Drug Approvals
›
Lundbeck Seattle BioPharmaceuticals, Inc.
›
BLA 761119
›
Letter
Application #761119
Documents
Letter
2021-09-28
Application Sponsors
BLA 761119
Lundbeck Seattle BioPharmaceuticals, Inc.
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.